Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28762 | 0.78 | — | — | |
| SCHEMBL28191514 | 0.77 | TSHR (0.32) | — | |
| SCHEMBL11691078 | 0.75 | — | — | |
| SCHEMBL12189743 | 0.75 | ALDH1A1 (0.46) | ALDH1A1ALOX15TRPA1PTPN1 | |
| SCHEMBL11874957 | 0.75 | TDP1 (0.30) | — | |
| Ethylene Glycol SCHEMBL5930511 | 0.74 | ALDH1A1 (0.55) | ALDH1A1ALOX15TRPA1PTPN1 | |
| SCHEMBL11059751 | 0.74 | ALDH1A1 (0.55) | ALDH1A1ALOX15TRPA1PTPN1 | |
| SCHEMBL7045168 | 0.73 | ALDH1A1 (0.50) | ALDH1A1ALOX15TRPA1PTPN1 | |
| SCHEMBL7045172 | 0.73 | ALDH1A1 (0.50) | ALDH1A1ALOX15TRPA1PTPN1 | |
| SCHEMBL7046628 | 0.73 | ALDH1A1 (0.50) | ALDH1A1ALOX15TRPA1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2747886-B1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH & CIE (CH) | 2018-11-14 | — | — | EP | disclosed |
| EP-2970067-B1 | SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH & CIE (CH) | 2017-08-16 | — | — | EP | disclosed |
| US-9714263-B2 | Selective hydrogenation of aldehydes with Ru/bidentate ligands complexes | FIRMENICH SA (CH) | 2017-07-25 | — | — | US | disclosed |
| US-20160039853-A1 | SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2016-02-11 | — | — | US | disclosed |
| EP-2970067-A1 | SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES | Firmenich SA (CH) | 2016-01-20 | — | — | EP | disclosed |
| US-9090534-B2 | Selective hydrogenation of aldehyde with ru/bidentate ligands complexes | FIREMENICH SA (CH) | 2015-07-28 | — | — | US | disclosed |
| US-9090534-B2 | Selective hydrogenation of aldehyde with ru/bidentate ligands complexes | FIREMENICH SA (CH) | 2015-07-28 | — | — | US | disclosed |
| US-9090534-B2 | Selective hydrogenation of aldehyde with ru/bidentate ligands complexes | FIREMENICH SA (CH) | 2015-07-28 | — | — | US | disclosed |
| WO-2014139854-A1 | SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2014-09-18 | — | — | WO | disclosed |
| US-20140243526-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2014-08-28 | — | — | US | disclosed |
| US-20140243526-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2014-08-28 | — | — | US | disclosed |
| US-20140243526-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2014-08-28 | — | — | US | disclosed |
| EP-2747886-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | Firmenich SA (CH) | 2014-07-02 | — | — | EP | disclosed |
| WO-2013050297-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2013-04-11 | — | — | WO | disclosed |
| WO-2013050297-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2013-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160039853-A1 | SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES | ADH5, ADH1A, ADH1C | ALDH1A1 56/4885ALOX15 685/4885TRPA1 1185/4885 |
| US-20140243526-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | ADH5, ADH1A, HAO2 | ALDH1A1 40/4885ALOX15 1041/4885TRPA1 1502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.